Home LiteratureArticle Details
PMID: 7338574 Published · ppublish English Comparative Study Journal Article

Comparative ototoxicity of bumetanide and furosemide when used in combination with kanamycin.

Journal of clinical pharmacology ·Vol. 21 ·No. 11 ·1981-00-00 ·Pages 628-36

Brummett RE, Bendrick T, Himes D

Abstract

The ototoxicity of bumetanide and furosemide was compared in Topeka strain guinea pigs pretreated with kanamycin. The animals, anesthetized with pentobarbital, received a single dose of 400 mg/kg kanamycin subcutaneously and the diuretics via indwelling catheter in the jugular vein 2 hours later. Ototoxic drug effects were determined by measuring the electrophysiological responses of the cochlea to sound stimuli and by determining the presence or absence of cochlear sensory hair cells from the organ of Corti. Both bumetanide and furosemide produced permanent alteration of cochlear activity in the kanamycin-pretreated animals. The ototoxic effect of bumetanide is five times that of furosemide on a milligram-for-milligram basis. The ototoxic potential of bumetanide is one eighth that of furosemide when the doses are adjusted for diuretic potency difference between the two diuretics.

MeSH Terms
Animals Bumetanide/administration & dosage,toxicity Cochlea/drug effects,physiology Diuretics/toxicity Dose-Response Relationship, Drug Drug Synergism Furosemide/administration & dosage,toxicity Guinea Pigs Kanamycin/administration & dosage,toxicity
Chemicals
Diuretics Bumetanide Kanamycin Furosemide
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Brummett R E
Bendrick T
Himes D
Article Info
Journal
Journal of clinical pharmacology
Abbr.
J Clin Pharmacol
ISSN
0091-2700
Published
1981-00-00
Pages
628-36
Language
English
Region
England
NLM ID
0366372
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com